Anne Moscona

Affiliations: 
Icahn School of Medicine at Mount Sinai, New York, NY, United States 
Area:
Microbiology Biology
Google:
"Anne Moscona"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Marcink TC, Zipursky G, Cheng W, et al. (2023) Subnanometer structure of an enveloped virus fusion complex on viral surface reveals new entry mechanisms. Science Advances. 9: eade2727
Reynard O, Gonzalez C, Dumont C, et al. (2022) Nebulized fusion inhibitory peptide protects cynomolgus macaques from measles virus infection. Nature Communications. 13: 6439
Schmitz KS, Geers D, de Vries RD, et al. (2022) Potency of Fusion-Inhibitory Lipopeptides against SARS-CoV-2 Variants of Concern. Mbio. 13: e0124922
Reynard O, Gonzalez C, Dumont C, et al. (2022) Nebulized fusion inhibitory peptide protects cynomolgus macaques from measles virus infection. Research Square
Kreft IC, Winiarczyk RRA, Tanis FJ, et al. (2021) Absence of COVID-19-associated changes in plasma coagulation proteins and pulmonary thrombosis in the ferret model. Thrombosis Research. 210: 6-11
Marcink TC, Porotto M, Moscona A. (2021) Parainfluenza virus entry at the onset of infection. Advances in Virus Research. 111: 1-29
Greninger AL, Rybkina K, Lin MJ, et al. (2021) Human parainfluenza virus evolution during lung infection of immunocompromised humans promotes viral persistence. The Journal of Clinical Investigation
Ferren M, Favède V, Decimo D, et al. (2021) Hamster organotypic modeling of SARS-CoV-2 lung and brainstem infection. Nature Communications. 12: 5809
Stelitano D, Weisberg SP, Goldklang MP, et al. (2021) Rapid and Flexible Platform To Assess Anti-SARS-CoV-2 Antibody Neutralization and Spike Protein-Specific Antivirals. Msphere. e0057121
Bovier FT, Rybkina K, Biswas S, et al. (2021) Inhibition of Measles Viral Fusion Is Enhanced by Targeting Multiple Domains of the Fusion Protein. Acs Nano
See more...